Research

Build evidence for your product faster with uMed's observational research study offering

One of the biggest challenges with running a Phase IV study is the cost which can in many cases be prohibitive particularly for a market like the UK.

uMed Research provides a solution which enable Life Sciences companies to run Phase IV observational studies in a cost effective and timely way.

Our process is the following:

  • Identify patients from their EHR record with inclusion/exclusion criteria to create an ideal cohort
  • Reach out to these patients via our GP network to consent and enrol them into the study
  • Collect patient report outcome data remotely
  • Integrate the data collected with the patient’s EHR record

In this way, we can quickly enrol a large number of patients into a study and scale the tracking of the patient reported outcomes in a cost effective way using our software platform/technology.

Whether it be building matched control arms to support your active monitoring study, demonstrating the effectiveness of Software as a Medical Device or making the case for changing the standard of care for your product area we can help you to quickly build evidence.

Please get in touch to find out more.

See patients in high definition

Through uMed’s data systems it’s possible to gather:

  • Patient Reported outcomes (ePro)
  • Custom Biomarker Samples
  • Genomics Data
  • and more…

What does the patient see?

We are currently building our first Recall study the effects of long-COVID. We also have a pipeline of cohorts across different therapy areas so please get in touch to discuss.

How does uMed | Research work?

uMed Platform Walkthrough

In four simple steps
  • Cohort Search
  • Provider Approval
  • Patient Engagement
  • Data Collection

The Cohort Search Results go to the Study Sponsor

uMed finds a specific cohort using de-identified EHR data from across our provider network. The Sponsor can choose regions or sites.

Provider Approval - Physicians for the identified patients can review their patient lists and approve or omit as required.

uMed digitally engages providers associated with the cohort identified in Step 1 for study authorization

Patient Engagement is the first patient contact.

The access request comes from the patient’s recognized medical provider. The patient is provided a weblink to follow. No app downloads are required.

Data Collection

ePRO data is collected directly from the patient and combined with the patient’s EMR data in a fully compliant manner.

Find out more

Book a complimentary demonstration

For a clear picture of how uMed could work for you, book a free session with our team.

    First name

    Last name

    Company or Institution

    Email

    Direct Line




    Set time
    Select a preferred time for us to call you

    Submit
    Thanks Robert, we’ll call you on 07338 238329 on Tuesday 27th July
    between 8am and 11am
    Close